SMi Source lesson Anticoagulation: Treatments I has the following microlearning topics
1. Introduction
2. Overview of Anticoagulation Therapy
3. Atrial Fibrillation Overview
4. Atrial Fibrillation Stroke Risk
5. Risk of Thromboembolism
6. Guidelines for Anticoagulation Therapy
7. Knowledge Check: Anticoagulant Prophylaxis
8. Knowledge Check: 2012 ACCP Guidelines for Antithrombotic Therapy
9. Knowledge Check: 2011 ACCF/AHA/HRS Recommendations for Antithrombotic Therapy
10. Venous Thromboembolism (VTE) Prophylaxis
11. VTE Prevention in Medical Patients
12. VTE Prevention in Medical Patients: Increased Risk for VTE
13. ACCP, AAOS, ASRA Compendium of Consensus Recommendations for VTE Prophylaxis
14. Prevention in Surgical Patients Non-Orthopedic Surgery
15. Prevention in Surgical Patients Non-Orthopedic Surgery: American College of Chest Physicians (ACCP) Guidelines
16. Prevention in Surgical Patients and Orthopedic Surgery
17. Prevention in Surgical Patients and Orthopedic Surgery: American College of Chest Physicians Guidelines
18. Knowledge Check: ACCP Guidelines
19. Knowledge Check: Anticoagulant Agents
20. Venous Thromboembolism Overview
21. Pulmonary Embolism
22. Pulmonary Embolism Treatment
23. Venous Thromboembolism Treatment
24. Venous Thromboembolism Treatment: Uncomplicated Initial Treatment
25. Venous Thromboembolism Treatment: Complications or Comorbidities
26. Venous Thromboembolism Treatment: Complications During Therapy
27. Venous Thromboembolism Treatment: ACCP Treatment Guidelines
28. Follow-Up and Secondary Prevention - Duration of Treatment
29. Follow-Up and Secondary Prevention: Bridging and Perioperative Management
30. Follow-Up and Secondary Prevention - Chronic Thromboembolic Pulmonary Hypertension
31. Knowledge Check: Initial Treatment of VTE
32. Knowledge Check: Contraindications to Anticoagulation
33. Knowledge Check: Anticoagulants
34. Standard Anticoagulants
35. Vitamin K Antagonists (VKAs)
36. Knowledge Check: Warfarin Dose Adjustment
37. Knowledge Check: International Normalized Ratio (INR)
38. Aspirin: Overview
39. Aspirin: Mechanism of Action
40. Knowledge Check: Aspirin
41. Unfractionated Heparin: Overview
42. Knowledge Check: Prescribing Information for Heparin
43. Knowledge Check: Complete Blood Cell Count (CBC)
44. Low-Molecular-Weight Heparin (LMWH)
45. Low-Molecular-Weight Heparin (LMWH): Dosage and Administration
46. Knowledge Check: Low-Molecular-Weight Heparins (LMWHs)
47. Knowledge Check: Enoxaparin and Dalteparin
48. Fondaparinux: Overview
49. Knowledge Check: Prescribing Information for Fondaparinux
50. Knowledge Check: Anticoagulant Mechanism of Action
51. Standard Agents: Clinical Studies
52. Vitamin K Antagonists (VKAs): Warfarin
53. Vitamin K Antagonists (VKAs) Warfarin: Acute Venous Thromboembolism (VTE)
54. Vitamin K Antagonists (VKAs) Warfarin: ACCP CHEST Guidelines
55. Vitamin K Antagonists (VKAs) Warfarin: Venous Thromboembolism (VTE)
56. Knowledge Check: Prevention of DVT in Surgical Patients
57. Knowledge Check: VTE Recurrence
58. Knowledge Check: Vitamin K Antagonist (VKA) Anticoagulant Treatment
59. Aspirin
60. Knowledge Check: Clinical Benefit of Aspirin
61. Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparins (LMWHs)
62. Recurrent Venous Thromboembolism (VTE)
63. Knowledge Check: LMWH vs. UFH
64. Fondaparinux: Clinical Studies
65. Knowledge Check: Fondaparinux
66. Knowledge Check: Fondaparinux Bleeding Events
67. Therapeutic Challenges of Antithrombotic Treatment
68. Vitamin K Antagonists (VKAs): Warfarin Contraindications
69. Vitamin K Antagonists (VKAs): Warfarin Special Considerations and Drug Interactions
70. Vitamin K Antagonists (VKAs): Warfarin Monitoring and Warfarin Anticoagulant Reversal
71. Knowledge Check: Warfarin Warnings and Precautions
72. Knowledge Check: INR Response
73. Aspirin: Warnings and Precautions
74. Aspirin: Anticoagulant Reversal
75. Knowledge Check: Aspirin Warnings and Precautions
76. Unfractionated Heparin: Warnings and Precautions
77. Unfractionated Heparin: Contraindications, Monitoring and Anticoagulation Reversal
78. Knowledge Check: Unfractionated Heparin Administration
79. Knowledge Check: Activated Partial Thromboplastin (aPTT)
80. Enoxaparin and Dalteparin: Boxed Warning
81. Enoxaparin: Warnings and Precautions
82. Enoxaparin: Contraindications and Dalteparin: Warnings and Precautions
83. Dalteparin Contraindications and Laboratory Monitoring
84. Fondaparinux: Boxed Warning
85. Fondaparinux: Warnings and Precautions
86. Fondaparinux: Contraindications, Laboratory Monitoring and Anticoagulant Reversal
87. Knowledge Check: Boxed Warning
88. Knowledge Check: Monitoring Low-Molecular-Weight Heparins and Fondaparinux
89. Knowledge Check: Contraindications to Fondaparinux
90. Knowledge Check: Reversal Agents
91. Table of Agents for Review
